Focus on P2X7R in microglia: its mechanism of action and therapeutic prospects in various neuropathic pain models
Frontiers in Pharmacology · 25.03.2025 · 16
DOI: 10.3389/fphar.2025.1555732 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 25.03.2025. Verfasst von Kai Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The Second Hospital of Lanzhou University, Lanzhou, China. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Neuropathic pain (NP) is a common symptom of many diseases and is caused by direct or indirect damage to the nervous system. Tricyclic antidepressants and serotonin-norepinephrine reuptake inhibitors are typical drugs used in clinical practice to suppress pain. However, these drugs have drawbacks, including a short duration of action, a limited analgesic effect, and possible dependence and side effects. Therefore, developing more effective NP treatment strategies has become a priority in medical research and has attracted much research attention. P2X7 receptor (P2X7R) is a non-selective cation channel activated by adenosine triphosphate and is mainly expressed in microglia in the central nervous system. Microglial P2X7R plays an important role in pain regulation, suggesting that it could be a potential target for drug development. This review comprehensively and objectively discussed the latest research progress of P2X7R, including its structural characteristics, functional properties, relationship with microglial activation and polarization, mechanism of action, and potential therapeutic strategies in multiple NP models. This study aimed to provide in-depth insights into the association between P2X7R and NP and explore the mechanism of action of P2X7R in the pathological process of NP and the translational potential and clinical application prospects of P2X7R antagonists in pain treatment, providing a scientific basis for the precise treatment of NP.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedics, The Second Hospital of Lanzhou University, Lanzhou, China.
- Orthopedics Key Laboratory of Gansu Province, Lanzhou, China.
- Lanzhou Biotechnique Development Co., Ltd., Lanzhou, China.
Zitieren
APA
Zhang, K., Ran, R., Zhang, C. J., Wang, L., & Zhang, H. H. (2025). Focus on P2X7R in microglia: its mechanism of action and therapeutic prospects in various neuropathic pain models. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1555732
Vancouver
Zhang K, Ran R, Zhang CJ, Wang L, Zhang HH. Focus on P2X7R in microglia: its mechanism of action and therapeutic prospects in various neuropathic pain models. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1555732
BibTeX
@article{Zhang2025,
author = {Zhang, Kai and Ran, Rui and Zhang, Cheng-Jun and Wang, Linna and Zhang, Hai-Hong},
title = {Focus on P2X7R in microglia: its mechanism of action and therapeutic prospects in various neuropathic pain models},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1555732}
}
EUVIMED